CompanyCore
UK company intelligence
Company profile report
Prepared 19 June 2026
AELIUS BIOTECH LIMITED
11535653 · ltd · incorporated 2018-08-24
1. Company facts
- Status
- active
- Lifecycle
- 🏛️ Established — Profitable, stable, 5+ years of trading. Classic SME profile.
- Jurisdiction
- england-wales
- Registered office
- Blandford Studios, 12 Blandford Square, Newcastle Upon Tyne, NE1 4HZ, United Kingdom
- SIC codes
- 72190 — Other research and experimental development on natural sciences and engineering; 86900 — Other human health activities
- Accounts next due
- 2026-09-30
- Confirmation statement next due
- 2026-06-15
2. Directors (4 active)
- CHATER, Peter Ian, Dr
- director · appointed 2019-04-25 · born 3/1986 (age 40)
- PEARSON, Jeffrey Peter
- director · appointed 2019-08-13 · born 7/1952 (age 74)
- WEAVER, Richard, Dr
- director · appointed 2023-11-20 · born 10/1969 (age 57)
- WILCOX, Matthew David, Dr
- director · appointed 2022-02-01 · born 7/1983 (age 43)
3. Shareholders (1 active)
- The North East (Erdf) Venture Capital Limited Partnership Acting By Its General Partner Enterprise Ventures (General Partner Ne Venture) Limited
- 25-50% shares · 25-50% voting
4. Group structure
The North East (Erdf) Venture Capital Limited Partnership Acting By Its General Partner Enterprise Ventures (General Partner Ne Venture) Limited holds 25-50% — a significant corporate investor but not a controlling parent.
- The North East (Erdf) Venture Capital Limited Partnership Acting By Its General Partner Enterprise Ventures (General Partner Ne Venture) Limited
- Corporate parent · 25-50%
5. Security
2 total charges (2 outstanding, 0 satisfied).
Headline verdict
- Opportunity score
- 68/100 (Strong)
- Owner dependency
- moderate — 55/100
- Red flags
- 1 high · 0 medium · 1 low